{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:59:26Z","timestamp":1792483166767,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T00:00:00Z","timestamp":1412035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s00198-014-2903-2","type":"journal-article","created":{"date-parts":[[2014,9,29]],"date-time":"2014-09-29T12:14:08Z","timestamp":1411992848000},"page":"431-441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"26","author":[{"given":"Y.-T.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-F.","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.-L.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,30]]},"reference":[{"issue":"2","key":"2903_CR1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bone.2010.05.019","volume":"47","author":"A Giusti","year":"2010","unstructured":"Giusti A, Hamdy NA, Papapoulos SE (2010) Atypical fractures of the femur and bisphosphonate therapy: a systematic review of case\/case series studies. Bone 47(2):169\u2013180. doi: 10.1016\/j.bone.2010.05.019","journal-title":"Bone"},{"issue":"2","key":"2903_CR2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2265.2009.03581.x","volume":"72","author":"CV Odvina","year":"2010","unstructured":"Odvina CV, Levy S, Rao S, Zerwekh JE, Rao DS (2010) Unusual mid-shaft fractures during long-term bisphosphonate therapy. Clin Endocrinol 72(2):161\u2013168. doi: 10.1111\/j.1365-2265.2009.03581.x","journal-title":"Clin Endocrinol"},{"issue":"12","key":"2903_CR3","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1007\/s11999-010-1583-2","volume":"468","author":"YC Ha","year":"2010","unstructured":"Ha YC, Cho MR, Park KH, Kim SY, Koo KH (2010) Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy? Clin Orthop Relat Res 468(12):3393\u20133398. doi: 10.1007\/s11999-010-1583-2","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"2903_CR4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/TA.0b013e31821957e3","volume":"71","author":"YA Weil","year":"2011","unstructured":"Weil YA, Rivkin G, Safran O, Liebergall M, Foldes AJ (2011) The outcome of surgically treated femur fractures associated with long-term bisphosphonate use. J Trauma 71(1):186\u2013190. doi: 10.1097\/TA.0b013e31821957e3","journal-title":"J Trauma"},{"issue":"34","key":"2903_CR5","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.1016\/j.biomaterials.2005.04.059","volume":"26","author":"F Knoch von","year":"2005","unstructured":"von Knoch F, Jaquiery C, Kowalsky M, Schaeren S, Alabre C, Martin I, Rubash HE, Shanbhag AS (2005) Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. Biomaterials 26(34):6941\u20136949. doi: 10.1016\/j.biomaterials.2005.04.059","journal-title":"Biomaterials"},{"issue":"12","key":"2903_CR6","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1172\/JCI39832","volume":"119","author":"H Li","year":"2009","unstructured":"Li H, Xie H, Liu W, Hu R, Huang B, Tan YF, Xu K, Sheng ZF, Zhou HD, Wu XP, Luo XH (2009) A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest 119(12):3666\u20133677. doi: 10.1172\/JCI39832","journal-title":"J Clin Invest"},{"issue":"14","key":"2903_CR7","doi-asserted-by":"crossref","first-page":"12328","DOI":"10.1074\/jbc.M110.176099","volume":"286","author":"R Hu","year":"2011","unstructured":"Hu R, Liu W, Li H, Yang L, Chen C, Xia ZY, Guo LJ, Xie H, Zhou HD, Wu XP, Luo XH (2011) A Runx2\/miR-3960\/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. J Biol Chem 286(14):12328\u201312339. doi: 10.1074\/jbc.M110.176099","journal-title":"J Biol Chem"},{"issue":"6","key":"2903_CR8","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.exphem.2011.01.011","volume":"39","author":"A Shah","year":"2011","unstructured":"Shah A, Ahmad A (2011) Role of microRNA in mesenchymal stem cells differentiation into osteoblasts. Exp Hematol 39(6):608\u2013616. doi: 10.1016\/j.exphem.2011.01.011","journal-title":"Exp Hematol"},{"issue":"3","key":"2903_CR9","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","volume":"90","author":"CV Odvina","year":"2005","unstructured":"Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90(3):1294\u20131301. doi: 10.1210\/jc.2004-0952","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2903_CR10","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1359\/jbmr.2002.17.12.2237","volume":"17","author":"Y Cao","year":"2002","unstructured":"Cao Y, Mori S, Mashiba T, Westmore MS, Ma L, Sato M, Akiyama T, Shi L, Komatsubara S, Miyamoto K, Norimatsu H (2002) Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats. J Bone Miner Res: Off J Am Soc Bone Miner Res 17(12):2237\u20132246. doi: 10.1359\/jbmr.2002.17.12.2237","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"issue":"1","key":"2903_CR11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10195-010-0083-1","volume":"11","author":"MA Matos","year":"2010","unstructured":"Matos MA, Tannuri U, Guarniero R (2010) The effect of zoledronate during bone healing. J Orthop Traumatol: Off J Italian Soc Orthop Traumatol 11(1):7\u201312. doi: 10.1007\/s10195-010-0083-1","journal-title":"J Orthop Traumatol: Off J Italian Soc Orthop Traumatol"},{"issue":"6","key":"2903_CR12","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1359\/jbmr.1999.14.6.969","volume":"14","author":"J Li","year":"1999","unstructured":"Li J, Mori S, Kaji Y, Mashiba T, Kawanishi J, Norimatsu H (1999) Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats. J Bone Miner Res: Off J Am Soc Bone Miner Res 14(6):969\u2013979. doi: 10.1359\/jbmr.1999.14.6.969","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"issue":"3","key":"2903_CR13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/jbmr.2001.16.3.429","volume":"16","author":"C Li","year":"2001","unstructured":"Li C, Mori S, Li J, Kaji Y, Akiyama T, Kawanishi J, Norimatsu H (2001) Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats. J Bone Miner Res: Off J Am Soc Bone Miner Res 16(3):429\u2013436. doi: 10.1359\/jbmr.2001.16.3.429","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"issue":"1","key":"2903_CR14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.vascn.2003.11.003","volume":"50","author":"F Bauss","year":"2004","unstructured":"Bauss F, Schenk RK, Hort S, Muller-Beckmann B, Sponer G (2004) New model for simulation of fracture repair in full-grown beagle dogs: model characterization and results from a long-term study with ibandronate. J Pharmacol Toxicol Methods 50(1):25\u201334. doi: 10.1016\/j.vascn.2003.11.003","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"11","key":"2903_CR15","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1359\/JBMR.040814","volume":"19","author":"CF Munns","year":"2004","unstructured":"Munns CF, Rauch F, Zeitlin L, Fassier F, Glorieux FH (2004) Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J Bone Miner Res: Off J Am Soc Bone Miner Res 19(11):1779\u20131786. doi: 10.1359\/JBMR.040814","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"issue":"5","key":"2903_CR16","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/17453670810016768","volume":"79","author":"SH Greiner","year":"2008","unstructured":"Greiner SH, Wildemann B, Back DA, Alidoust M, Schwabe P, Haas NP, Schmidmaier G (2008) Local application of zoledronic acid incorporated in a poly(D, L-lactide)-coated implant accelerates fracture healing in rats. Acta Orthop 79(5):717\u2013725. doi: 10.1080\/17453670810016768","journal-title":"Acta Orthop"},{"issue":"4","key":"2903_CR17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jhsa.2008.12.011","volume":"34","author":"TD Rozental","year":"2009","unstructured":"Rozental TD, Vazquez MA, Chacko AT, Ayogu N, Bouxsein ML (2009) Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy. J Hand Surg 34(4):595\u2013602. doi: 10.1016\/j.jhsa.2008.12.011","journal-title":"J Hand Surg"},{"issue":"5","key":"2903_CR18","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.orthres.2005.03.004","volume":"23","author":"N Amanat","year":"2005","unstructured":"Amanat N, Brown R, Bilston LE, Little DG (2005) A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair. J Orthop Res: Off Publ Orthop Res Soc 23(5):1029\u20131034. doi: 10.1016\/j.orthres.2005.03.004","journal-title":"J Orthop Res: Off Publ Orthop Res Soc"},{"issue":"Suppl 7","key":"2903_CR19","first-page":"S53","volume":"5","author":"AE Goodship","year":"1994","unstructured":"Goodship AE, Walker PC, McNally D, Chambers T, Green JR (1994) Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone. Ann Oncol 5(Suppl 7):S53\u2013S55","journal-title":"Ann Oncol"},{"issue":"11","key":"2903_CR20","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1359\/JBMR.050712","volume":"20","author":"DG Little","year":"2005","unstructured":"Little DG, McDonald M, Bransford R, Godfrey CB, Amanat N (2005) Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model. J Bone Miner Res: Off J Am Soc Bone Miner Res 20(11):2044\u20132052. doi: 10.1359\/JBMR.050712","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"issue":"4","key":"2903_CR21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00586-006-0212-y","volume":"16","author":"R Bransford","year":"2007","unstructured":"Bransford R, Goergens E, Briody J, Amanat N, Cree A, Little D (2007) Effect of zoledronic acid in an L6-L7 rabbit spine fusion model. Eur Spine J: Off Publ Eur Spine Soc Eur Spinal Deform Soc Eur Section Cervical Spine Res Soc 16(4):557\u2013562. doi: 10.1007\/s00586-006-0212-y","journal-title":"Eur Spine J: Off Publ Eur Spine Soc Eur Spinal Deform Soc Eur Section Cervical Spine Res Soc"},{"issue":"6","key":"2903_CR22","doi-asserted-by":"crossref","first-page":"e991","DOI":"10.3928\/01477447-20120525-51","volume":"35","author":"MK Grady","year":"2012","unstructured":"Grady MK, Watson JT, Cannada LK (2012) Treatment of femoral fracture nonunion after long-term bisphosphonate use. Orthopedics 35(6):e991\u2013e995. doi: 10.3928\/01477447-20120525-51","journal-title":"Orthopedics"},{"key":"2903_CR23","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1016\/j.rehab.2011.07.957","volume":"54","author":"F Benlebna","year":"2011","unstructured":"Benlebna F, El AF, Boumediene ZB, El KM, Medghar S, Djaroud Z (2011) Delay of consolidation and bisphosphonates: two cases. Ann Phys Rehabil Med 54:e182\u2013e183","journal-title":"Ann Phys Rehabil Med"},{"key":"2903_CR24","doi-asserted-by":"crossref","first-page":"S220","DOI":"10.1007\/s00198-010-1502-0","volume":"22","author":"E Czerwinski","year":"2011","unstructured":"Czerwinski E, Osieleniec J, Loranc A (2011) Delayed union after atypical subtrochanteric fracture under alendronate treatment: case report. Osteoporos Int 22:S220","journal-title":"Osteoporos Int"},{"issue":"4","key":"2903_CR25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00701-012-1283-7","volume":"154","author":"C Li","year":"2012","unstructured":"Li C, Wang HR, Li XL, Zhou XG, Dong J (2012) The relation between zoledronic acid infusion and interbody fusion in patients undergoing transforaminal lumbar interbody fusion surgery. Acta Neurochir (Wien) 154(4):731\u2013738. doi: 10.1007\/s00701-012-1283-7","journal-title":"Acta Neurochir (Wien)"},{"key":"2903_CR26","author":"C Colon-Emeric","year":"2011","unstructured":"Colon-Emeric C, Nordsletten L, Olson S, Major N, Boonen S, Haentjens P, Mesenbrink P, Magaziner J, Adachi J, Lyles KW, Hyldstrup L, Bucci-Rechtweg C, Recknor C (2011) Association between timing of zoledronic acid infusion and hip fracture healing, vol 22. Osteoporos Int. doi: 10.1007\/s00198-010-1473-1","journal-title":"Osteoporos Int"},{"issue":"18","key":"2903_CR27","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","volume":"357","author":"KW Lyles","year":"2007","unstructured":"Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S, Trial HRF (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799\u20131809. doi: 10.1056\/NEJMoa074941","journal-title":"N Engl J Med"},{"issue":"4","key":"2903_CR28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/ans.12536","volume":"84","author":"AJ Ng","year":"2014","unstructured":"Ng AJ, Yue B, Joseph S, Richardson M (2014) Delayed\/non-union of upper limb fractures with bisphosphonates: systematic review and recommendations. ANZ J Surg 84(4):218\u2013224. doi: 10.1111\/ans.12536","journal-title":"ANZ J Surg"},{"issue":"11","key":"2903_CR29","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1302\/0301-620X.95B11.31652","volume":"95-B","author":"S Uchiyama","year":"2013","unstructured":"Uchiyama S, Itsubo T, Nakamura K, Fujinaga Y, Sato N, Imaeda T, Kadoya M, Kato H (2013) Effect of early administration of alendronate after surgery for distal radial fragility fracture on radiological fracture healing time. Bone Joint J 95-B(11):1544\u20131550. doi: 10.1302\/0301-620x.95b11.31652","journal-title":"Bone Joint J"},{"key":"2903_CR30","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1302\/0301-620X.94B7.29079","volume":"94","author":"TY Kim","year":"2012","unstructured":"Kim TY, Ha YC, Kang BJ, Lee YK, Koo KH (2012) Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures? J Bone Joint Surg Br Vol 94:956\u2013960. doi: 10.1302\/0301-620x.94b7.29079","journal-title":"J Bone Joint Surg Br Vol"},{"key":"2903_CR31","author":"HS Gong","year":"2012","unstructured":"Gong HS, Song CH, Lee YH, Rhee SH, Lee HJ, Baek GH (2012) Early initiation of bisphosphonate does not affect healing and outcomes of volar plate fixation of osteoporotic distal radial fractures, vol 94. J Bone Joint Surg Am Vol. doi: 10.2106\/jbjs.k.01434","journal-title":"J Bone Joint Surg Am Vol"},{"issue":"4","key":"2903_CR32","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/17453674.2011.594231","volume":"82","author":"AK Harding","year":"2011","unstructured":"Harding AK, W-Dahl A, Geijer M, Toksvig-Larsen S, Tagil M (2011) A single bisphosphonate infusion does not accelerate fracture healing in high tibial osteotomies. Acta Orthop 82(4):465\u2013470. doi: 10.3109\/17453674.2011.594231","journal-title":"Acta Orthop"},{"issue":"3","key":"2903_CR33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bone.2009.10.040","volume":"46","author":"AK Harding","year":"2010","unstructured":"Harding AK, Toksvig-Larsen S, Tagil M, W-Dahl A (2010) A single dose zoledronic acid enhances pin fixation in high tibial osteotomy using the hemicallotasis technique. A double-blind placebo controlled randomized study in 46 patients. Bone 46(3):649\u2013654. doi: 10.1016\/j.bone.2009.10.040","journal-title":"Bone"},{"issue":"6","key":"2903_CR34","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00198-008-0767-z","volume":"20","author":"D Cecilia","year":"2009","unstructured":"Cecilia D, Jodar E, Fernandez C, Resines C, Hawkins F (2009) Effect of alendronate in elderly patients after low trauma hip fracture repair. Osteoporos Int 20(6):903\u2013910. doi: 10.1007\/s00198-008-0767-z","journal-title":"Osteoporos Int"},{"issue":"2","key":"2903_CR35","first-page":"132","volume":"41","author":"F Altintas","year":"2007","unstructured":"Altintas F, Ozkut AT, Beyzadeoglu T, Eren A, Guven M (2007) The effect of risedronate treatment on bone turnover markers in patients with hip fracture. Acta Orthop Traumatol Turc 41(2):132\u2013135","journal-title":"Acta Orthop Traumatol Turc"},{"issue":"4","key":"2903_CR36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.PHM.0000122877.28631.23","volume":"83","author":"Y Sato","year":"2004","unstructured":"Sato Y, Kanoko T, Yasuda H, Satoh K, Iwamoto J (2004) Beneficial effect of etidronate therapy in immobilized hip fracture patients. Am J Phys Med Rehabil 83(4):298\u2013303. doi: 10.1097\/01.PHM.0000122877.28631.23","journal-title":"Am J Phys Med Rehabil"},{"issue":"12","key":"2903_CR37","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1359\/jbmr.2002.17.12.2247","volume":"17","author":"CE Poest van der","year":"2002","unstructured":"van der Poest CE, van Engeland M, Ader H, Roos JC, Patka P, Lips P (2002) Alendronate in the prevention of bone loss after a fracture of the lower leg. J Bone Miner Res 17(12):2247\u20132255. doi: 10.1359\/jbmr.2002.17.12.2247","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2903_CR38","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1111\/j.1532-5415.2011.03666.x","volume":"59","author":"S Boonen","year":"2011","unstructured":"Boonen S, Orwoll E, Magaziner J, Colon-Emeric CS, Adachi JD, Bucci-Rechtweg C, Haentjens P, Kaufman JM, Rizzoli R, Vanderschueren D, Claessens F, Sermon A, Witvrouw R, Milisen K, Su G, Lyles KW (2011) Once-yearly zoledronic acid in older men compared with women with recent hip fracture. J Am Geriatr Soc 59(11):2084\u20132090. doi: 10.1111\/j.1532-5415.2011.03666.x","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"2903_CR39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00223-011-9543-8","volume":"89","author":"JD Adachi","year":"2011","unstructured":"Adachi JD, Lyles K, Boonen S, Colon-Emeric C, Hyldstrup L, Nordsletten L, Pieper C, Recknor C, Su G, Bucci-Rechtweg C, Magaziner J (2011) Subtrochanteric fractures in bisphosphonate-naive patients: results from the HORIZON-Recurrent Fracture Trial. Calcif Tissue Int 89(6):427\u2013433. doi: 10.1007\/s00223-011-9543-8","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"2903_CR40","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00223-011-9474-4","volume":"88","author":"CS Colon-Emeric","year":"2011","unstructured":"Colon-Emeric CS, Lyles KW, Su G, Pieper CF, Magaziner JS, Adachi JD, Bucci-Rechtweg CM, Haentjens P, Boonen S (2011) Clinical risk factors for recurrent fracture after hip fracture: a prospective study. Calcif Tissue Int 88(5):425\u2013431. doi: 10.1007\/s00223-011-9474-4","journal-title":"Calcif Tissue Int"},{"issue":"9","key":"2903_CR41","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1007\/s00198-010-1514-9","volume":"22","author":"JD Adachi","year":"2011","unstructured":"Adachi JD, Lyles KW, Colon-Emeric CS, Boonen S, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Bucci-Rechtweg C, Su G, Eriksen EF, Magaziner JS (2011) Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON-Recurrent Fracture Trial. Osteoporos Int 22(9):2539\u20132549. doi: 10.1007\/s00198-010-1514-9","journal-title":"Osteoporos Int"},{"issue":"8","key":"2903_CR42","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s00198-010-1473-1","volume":"22","author":"C Colon-Emeric","year":"2011","unstructured":"Colon-Emeric C, Nordsletten L, Olson S, Major N, Boonen S, Haentjens P, Mesenbrink P, Magaziner J, Adachi J, Lyles KW, Hyldstrup L, Bucci-Rechtweg C, Recknor C (2011) Association between timing of zoledronic acid infusion and hip fracture healing. Osteoporos Int 22(8):2329\u20132336. doi: 10.1007\/s00198-010-1473-1","journal-title":"Osteoporos Int"},{"issue":"2","key":"2903_CR43","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1532-5415.2009.02673.x","volume":"58","author":"S Boonen","year":"2010","unstructured":"Boonen S, Black DM, Colon-Emeric CS, Eastell R, Magaziner JS, Eriksen EF, Mesenbrink P, Haentjens P, Lyles KW (2010) Efficacy and safety of a once-yearly intravenous zoledronic acid 5\u00a0mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older. J Am Geriatr Soc 58(2):292\u2013299. doi: 10.1111\/j.1532-5415.2009.02673.x","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"2903_CR44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1359\/jbmr.090704","volume":"25","author":"CS Colon-Emeric","year":"2010","unstructured":"Colon-Emeric CS, Mesenbrink P, Lyles KW, Pieper CF, Boonen S, Delmas P, Eriksen EF, Magaziner J (2010) Potential mediators of the mortality reduction with zoledronic acid after hip fracture. J Bone Miner Res 25(1):91\u201397. doi: 10.1359\/jbmr.090704","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2903_CR45","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1359\/jbmr.090209","volume":"24","author":"EF Eriksen","year":"2009","unstructured":"Eriksen EF, Lyles KW, Colon-Emeric CS, Pieper CF, Magaziner JS, Adachi JD, Hyldstrup L, Recknor C, Nordsletten L, Lavecchia C, Hu H, Boonen S, Mesenbrink P (2009) Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture. J Bone Miner Res 24(7):1308\u20131313. doi: 10.1359\/jbmr.090209","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2903_CR46","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1185\/030079904125003683","volume":"20","author":"CS Colon-Emeric","year":"2004","unstructured":"Colon-Emeric CS, Caminis J, Suh TT, Pieper CF, Janning C, Magaziner J, Adachi J, Rosario-Jansen T, Mesenbrink P, Horowitz ZD, Lyles KW (2004) The HORIZON Recurrent Fracture Trial: design of a clinical trial in the prevention of subsequent fractures after low trauma hip fracture repair. Curr Med Res Opin 20(6):903\u2013910. doi: 10.1185\/030079904125003683","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"2903_CR47","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2106\/JBJS.F.00484","volume":"89","author":"A Moroni","year":"2007","unstructured":"Moroni A, Faldini C, Hoang-Kim A, Pegreffi F, Giannini S (2007) Alendronate improves screw fixation in osteoporotic bone. J Bone Joint Surg Am 89(1):96\u2013101. doi: 10.2106\/jbjs.f.00484","journal-title":"J Bone Joint Surg Am"},{"issue":"7","key":"2903_CR48","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1210\/jc.2012-1027","volume":"97","author":"S Khosla","year":"2012","unstructured":"Khosla S, Bilezikian JP, Dempster DW, Lewiecki EM, Miller PD, Neer RM, Recker RR, Shane E, Shoback D, Potts JT (2012) Benefits and risks of bisphosphonate therapy for osteoporosis. J Clin Endocrinol Metab 97(7):2272\u20132282. doi: 10.1210\/jc.2012-1027","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2903_CR49","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00223-012-9587-4","volume":"90","author":"J Goldhahn","year":"2012","unstructured":"Goldhahn J, Feron JM, Kanis J, Papapoulos S, Reginster JY, Rizzoli R, Dere W, Mitlak B, Tsouderos Y, Boonen S (2012) Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper. Calcif Tissue Int 90(5):343\u2013353. doi: 10.1007\/s00223-012-9587-4","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"2903_CR50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11914-011-0065-0","volume":"9","author":"NR Jorgensen","year":"2011","unstructured":"Jorgensen NR, Schwarz P (2011) Effects of anti-osteoporosis medications on fracture healing. Curr Osteoporos Rep 9(3):149\u2013155. doi: 10.1007\/s11914-011-0065-0","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"2903_CR51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11914-005-0018-6","volume":"3","author":"PD Miller","year":"2005","unstructured":"Miller PD (2005) Bone density and markers of bone turnover in predicting fracture risk and how changes in these measures predict fracture risk reduction. Curr Osteoporos Rep 3(3):103\u2013110. doi: 10.1007\/s11914-005-0018-6","journal-title":"Curr Osteoporos Rep"},{"issue":"5","key":"2903_CR52","first-page":"285","volume":"42","author":"P Coates","year":"2013","unstructured":"Coates P (2013) Bone turnover markers. Aust Fam Physician 42(5):285\u2013287","journal-title":"Aust Fam Physician"},{"issue":"2","key":"2903_CR53","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0162-0134(90)84019-L","volume":"38","author":"AS Klemens","year":"1990","unstructured":"Klemens AS, McMillin DR (1990) New method for removing type 2 copper from Rhus laccase. J Inorg Biochem 38(2):107\u2013115. doi: 10.1016\/0162-0134(90)84019-L","journal-title":"J Inorg Biochem"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2903-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-014-2903-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2903-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:15:17Z","timestamp":1558610117000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-014-2903-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,30]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["2903"],"URL":"https:\/\/doi.org\/10.1007\/s00198-014-2903-2","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,30]]}}}